Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Ornithine Transcarbamylase (OTC) Deficiency
Clinical Trial
NCT02991144Last updated: 12/4/2025
RARE
Ultragenyx Pharmaceutical Inc.